The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation (Q41706054)

7 October 2017

title

The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation (English)

1 reference

7 October 2017

Webster SD

1

1 reference

7 October 2017

Tenner AJ

series ordinal

2

1 reference

7 October 2017

Poulos TL

series ordinal

3

1 reference

7 October 2017

Cribbs DH

series ordinal

4

1 reference

7 October 2017

publication date

1 May 1999

1 reference

7 October 2017

published in

Neurobiology of Aging

1 reference

7 October 2017

volume

20

1 reference

7 October 2017

issue

3

1 reference

7 October 2017

page(s)

297-304

1 reference

Localization and cell association of C1q in Alzheimer's disease brain

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Development and characterization of a hemolytic assay for mouse C4

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

beta-Amyloid converts an acute phase injury response to chronic injury responses

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Complement activation by cross-linked truncated and chimeric full-length beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Inflammatory mechanisms in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Structural model of the collagen-like region of C1q comprising the kink region and the fibre-like packing of the six triple helices.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Mouse strains with typical mammalian levels of complement activity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Treatment of Alzheimer's disease: current approaches and promising developments.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

Regulation of mouse serum amyloid P gene expression by cytokines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900020-2

7 January 2021

10.1016/S0197-4580(99)00020-2

Identifiers

DOI

1 reference

7 October 2017

1 reference